APN News

  • Friday, September, 2023| Today's Market | Current Time: 07:08:40
  • Best Agrolife: Revenue Crosses Rs. 1,700 cr., EBITDA Margin Reaches 18%, and 30% Dividend Recommended in FY23

    Published on May 31, 2023

    New Delhi : Best AgrolifeLimited (BAL)(BSE: 539660, NSE: BESTAGRO) today reported financial results for the Quarterand YearendedMarch31st, 2023.

    Consolidated Financial Results –FY23& Q4

    Particulars (Rs. Cr)FY23FY22YoY
    Revenue from Operations1,7461,21144%
    Gross Profit494226119%

    Commenting on results, Mr. Vimal Alawadhi,Managing Director, Best Agrolife Limited,said: “I am delighted to inform you that we have delivered strong revenue from operationsof Rs. 1,746 cr. which is a robust growth of 44% over FY22. Our constant focus on introducing the innovative products to cater to farmers need has resulted in BAL introducing many specialised combination products including patented novel combination Ronfenin FY23which drove the growth during the year. We have also expanded our margins by 427 bps during the year which was driven by change in product mix.”

    Best AgrolifeBoard has also recommended a dividend of 30% (i.e. Rs.3 per share), which is 50% jump over last year.

    Q4FY23 was difficult for the industry at large due to higher channel inventory and excess supply from China at lower prices. Best Agrolife was also affected by this as its branded product portfoliois more focused on the kharif season.The company is working towards introducing more branded products which are focused on Rabi season which will improve breadth of the portfolio and will also make the portfolio more balanced which is currently skewed more towards kharif season.

    In line with its commitment to “Make in India”, Best Agrolife hasembarked on a capex plan to expandits technical capabilities as well as improve backward integration which will lead to lower dependence on China and better cost structure.

    Overall, the company has an exciting product pipeline ready to be launched in FY24 which are in line with its strategy of introducing more patented and specialised combination products which will help continuestronggrowth momentum as well as improve the marginsin FY24.”

    Key Results Highlights (FY23 Consolidated):

    • Revenuefrom operations for FY23 grew by 44% YoY to Rs. 1,746cr.
    • Gross margin for the year is at 28% as compared to 19% in FY22 which was an expansion of 963 bps YoY.
    • EBITDA for the year came at Rs. 314cr up 89% YoY compared to Rs. 166cr in FY22.
    • EBITDA margin for the year came at 18% as compared to 14% in FY22; expansion of 427 bps YoY.
    • PAT for the year was at Rs. 192cr up 83%on YoY basis. PAT margin for the year was at 11%compared to 9% in FY22.

    Key Business highlights for FY23:

    • Products Launched during FY23:
      • Launched a first-of-its-kind proprietary ternary insecticidal combination — Ronfen.  Ronfen is a single-shot solution that controls all sucking pests in various crops like cotton, chilly, vegetables, and many other segments having addressable market of ~Rs. 8,000cr.
      • Best Group became the first company to launch CTPR based formulations CITIGEN & VISTARA in domestic market. This single molecule has around Rs 2,800 cr. domestic market.
      • BAL also launched niche combination products such as Tambo, Axeman, Warden and Reveal during FY23.
    • Approvals and Registration received:
      • Seedlings India Pvt Ltd wholly- owned subsidiary of BAL received a patent valid for 20 years for the first-of-its-kind fungicidal composition of Cyazofamid, Dimethomorph, and Difenoconazole which is going to emerge as a highly effective crop solution against Late Blight and Downy Mildew in tomato and grapes crops respectively.Theapproximate market size of this fungicidal composition is ₹350 crore.
      • Granted registration for indigenous manufacturing of Pyroxasulfone technical u/s 9(3). The market size of Pyroxasulfoneis approximately ₹ 450 Crore and is expected to grow in coming years.Until now India was dependent on other countries for Pyroxasulfone.
      • Granted registration for the indigenous manufacturing of Propiquazafop u/s 9(3).
      • Granted registration for the indigenous manufacturing of Cyhalofop-Butyl Technical, u/s 9(3).
    • Capex Update:
      • Board of directors approved Capex plan of Rs. 200 cr. towards brownfield expansion in the technical manufacturing unit of Best Crop Science Private Limited (a wholly owned subsidiary of the Company).

    Product Pipeline for FY24:

    • BAL has pipeline of10+ products to be launched during the course of FY24 which includes couple of patented products as well as some niche combination products and technicals.


    Leave a Reply